Haisco Pharmaceutical Group Co., Ltd. Stock Price

SZSE:002653 Community·CN¥57.9b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

002653 Share Price Performance

CN¥52.17

17.32 (49.70%)

CN¥52.17

17.32 (49.70%)

CN¥52.17

Wed, 17 Dec 25

Share Pricen/a

002653 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

3 Risks

1 Reward

View Full Analysis

Haisco Pharmaceutical Group Co., Ltd. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 0.28
: 72.65%
: 7.23%
: 54.8%

View Full Analysis

About 002653

Founded: 2000
Employees: 5337
CEO: Xiu Lian Fan
WebsiteView website: www.haisco.com

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.